Page last updated: 2024-08-25

fosquidone and Cancer of Ovary

fosquidone has been researched along with Cancer of Ovary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cavalli, F; Clavel, M; Judson, IR; Kaye, SB; Piccart, MJ; Smyth, JF; Ten Bokkel Huinink, WW; Verweij, J; Wagener, DJ; Wanders, J1
Boven, E; Erkelens, CA; Luning, M; Pinedo, HM1

Trials

1 trial(s) available for fosquidone and Cancer of Ovary

ArticleYear
Phase II trials of fosquidone (GR63178A) in carcinoma of the breast, head and neck, ovary and melanoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Isoquinolines; Male; Melanoma; Middle Aged; Organophosphorus Compounds; Ovarian Neoplasms

1992

Other Studies

1 other study(ies) available for fosquidone and Cancer of Ovary

ArticleYear
Activity of GR30921X (NSC 382057) and GR63178A (NSC D611615) in human ovarian cancer lines.
    British journal of cancer, 1990, Volume: 61, Issue:5

    Topics: Animals; Antineoplastic Agents; Cell Line; Female; Humans; Isoindoles; Isoquinolines; Mice; Mice, Nude; Neoplasm Transplantation; Organophosphorus Compounds; Ovarian Neoplasms; Quinones

1990